Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 11, 2023

BUY
$118.38 - $210.04 $710 - $1,260
6 New
6 $0
Q2 2022

Jul 19, 2022

SELL
$117.13 - $176.59 $8,784 - $13,244
-75 Reduced 60.0%
50 $7,000
Q1 2021

Apr 19, 2021

SELL
$109.18 - $185.98 $5,459 - $9,299
-50 Reduced 28.57%
125 $16,000
Q3 2020

Oct 13, 2020

SELL
$54.34 - $94.85 $1,901 - $3,319
-35 Reduced 16.67%
175 $12,000
Q1 2020

Apr 23, 2020

BUY
$17.78 - $31.58 $3,733 - $6,631
210 New
210 $6,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.